Your browser doesn't support javascript.
loading
Long-term glycaemic control with metformin-sulphonylurea-pioglitazone triple therapy in PROactive (PROactive 17).
Scheen, A J; Tan, M H; Betteridge, D J; Birkeland, K; Schmitz, O; Charbonnel, B.
Affiliation
  • Scheen AJ; Division of Diabetes, Nutrition and Metabolic Disorders, Department of Medicine, University of Liège, B-4000 Liège, Belgium. andre.Scheen@chu.ulg.ac.be
Diabet Med ; 26(10): 1033-9, 2009 Oct.
Article in En | MEDLINE | ID: mdl-19900236
Subject(s)
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Sulfonylurea Compounds / Blood Glucose / Glycated Hemoglobin / Thiazolidinediones / Diabetes Mellitus, Type 2 / Metformin Type of study: Clinical_trials Limits: Adult / Aged / Female / Humans / Male / Middle aged Language: En Journal: Diabet Med Journal subject: ENDOCRINOLOGIA Year: 2009 Document type: Article Affiliation country: Country of publication:
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Sulfonylurea Compounds / Blood Glucose / Glycated Hemoglobin / Thiazolidinediones / Diabetes Mellitus, Type 2 / Metformin Type of study: Clinical_trials Limits: Adult / Aged / Female / Humans / Male / Middle aged Language: En Journal: Diabet Med Journal subject: ENDOCRINOLOGIA Year: 2009 Document type: Article Affiliation country: Country of publication: